Mary Kay Fenton
Chief Financial Officer · Cullinan Therapeutics, Inc.
- 2026
- Jul 2, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mary Kay Fenton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lynx1 Capital Management LP - $3.50M in CGEM purchases and sales in the last 12 months
- Jennifer Michaelson - $1.62M in CGEM purchases and sales in the last 12 months
- Nadim Ahmed - $518K in CGEM purchases and sales in the last 12 months
- Jeffrey Alan Jones - $179K in CGEM purchases and sales in the last 12 months
- Jacquelyn L. Sumer - $137K in CGEM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mary Kay Fenton?
Mary Kay Fenton is a corporate insider, tracked as Chief Financial Officer of Cullinan Therapeutics, Inc. (CGEM). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mary Kay Fenton last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 4 filings going back to 2026.
Has Mary Kay Fenton been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($60K) across all tracked filings.
